Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 25,005
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12559523 | Compositions comprising chemerin analogs and methods of use | 🖼🧊📄§ | 2026-02-24 | 2040-07-29 | 0 | 31 |
| 12559549 | Antibody binding to super-repressor IκB (srIκB) or antigen binding fragment thereof | 🖼🧊📄§ | 2026-02-24 | 2040-12-31 | 0 | 31 |
| 12558411 | Antigen composition for preventing or treating viral infectious diseases | 🖼🧊📄§ | 2026-02-24 | 2041-01-15 | 0 | 31 |
| 12558303 | Manufacture, isolation, purification, and uses of small particle size cellulose particles and compositions | 🖼🧊📄§ | 2026-02-24 | 2043-06-14 | 0 | 31 |
| 12559538 | PD-1 polypeptide variants | 🖼🧊📄§ | 2026-02-24 | 2041-09-08 | 0 | 31 |
| 12559544 | Antibodies that bind human metapneumovirus fusion protein and their use | 🖼🧊📄§ | 2026-02-24 | 2040-05-20 | 0 | 31 |
| 12558418 | Egg allergy antigen | 🖼🧊📄§ | 2026-02-24 | 2043-08-03 | 0 | 31 |
| 12559458 | Co-crystals or salts of psilocin and methods of treatment therewith | 🖼🧊📄§ | 2026-02-24 | 2043-03-03 | 0 | 31 |
| 12559451 | System for producing remote sensing data from near earth orbit | 🖼🧊📄§ | 2026-02-24 | 2045-03-13 | 0 | 31 |
| 12558402 | Jellyfish collagen use | 🖼🧊📄§ | 2026-02-24 | 2041-06-15 | 0 | 31 |
| 12559718 | Diagnostic methods for t cell therapy | 🖼🧊📄§ | 2026-02-24 | 2043-08-24 | 0 | 31 |
| 12558374 | Botanical film-forming acne compositions | 🖼🧊📄§ | 2026-02-24 | 2043-10-12 | 0 | 31 |
| 12558331 | Pregabalin formulations and use thereof | 🖼🧊📄§ | 2026-02-24 | 2040-03-26 | 0 | 31 |
| 12558401 | Insulinotropic and glucagonotropic effects of beta-lactoglobulin | 🖼🧊📄§ | 2026-02-24 | 2040-11-20 | 0 | 31 |
| 12558437 | Compositions and methods for epigenetic regulation of HBV gene expression | 🖼🧊📄§ | 2026-02-24 | 2044-07-02 | 0 | 31 |
| 12558325 | Methods for improving neurological diseases and disorders | 🖼🧊📄§ | 2026-02-24 | 2043-02-09 | 0 | 31 |
| 12558388 | Use of radix actinidiae chinensis and extract thereof in preparation of medicine for treating ulcerative colitis | 🖼🧊📄§ | 2026-02-24 | 2044-01-12 | 0 | 31 |
| 12558389 | Plant-based extract complex composition having the properties for supporting the relief of musculoskeletal pain, antibacterial and anti-inflammatory and process of manufacturing the same | 🖼🧊📄§ | 2026-02-24 | 2045-07-21 | 0 | 31 |
| 12559485 | CDK6/DYRK2 dual-target inhibitor, and preparation method therefor and use thereof | 🖼🧊📄§ | 2026-02-24 | 2041-03-19 | 0 | 31 |
| 12559450 | Lipidoids for nucleic acid transfection and use thereof | 🖼🧊📄§ | 2026-02-24 | 2041-07-23 | 0 | 31 |
| 12559769 | Methods and compositions for the activation of tumor cytotoxicity via human gamma-delta t-cells | 🖼🧊📄§ | 2026-02-24 | 2038-06-15 | 0 | 31 |
| 12558410 | Lassavirus vaccines | 🖼🧊📄§ | 2026-02-24 | 2040-09-11 | 0 | 31 |
| 12559473 | Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugs | 🖼🧊📄§ | 2026-02-24 | 2044-04-30 | 0 | 31 |
| 12559576 | CD20-PD1 binding molecules and methods of use thereof | 🖼🧊📄§ | 2026-02-24 | 2042-11-09 | 0 | 31 |
| 12558354 | Tumor necrosis factor alpha (TNF-alpha) small molecule inhibitor | 🖼🧊📄§ | 2026-02-24 | 2040-11-05 | 0 | 31 |
| 12558399 | Isocyclosporin A for topical treatment of ocular diseases | 🖼🧊📄§ | 2026-02-24 | 2042-12-22 | 0 | 31 |
| 12559725 | Formulation comprising extracellular vesicles, method for producing the same, and uses thereof | 🖼🧊📄§ | 2026-02-24 | 2039-12-04 | 0 | 31 |
| 12558353 | Method of reducing pulmonary exacerbations in respiratory disease patients | 🖼🧊📄§ | 2026-02-24 | 2043-12-20 | 0 | 31 |
| 12559572 | Compositions and methods for treating IgE-mediated disorders | 🖼🧊📄§ | 2026-02-24 | 2042-12-22 | 0 | 31 |
| 12559539 | TGF-beta receptor fusion protein pharmaceutical composition and use thereof | 🖼🧊📄§ | 2026-02-24 | 2039-11-08 | 0 | 31 |
| 12558363 | Compositions for clinical complications associated to devices implanted in the urinary tract | 🖼🧊📄§ | 2026-02-24 | 2040-12-29 | 0 | 31 |
| 12558344 | Composition for preventing or treating brain-nervous system diseases comprising rita or derivatives thereof | 🖼🧊📄§ | 2026-02-24 | 2042-06-03 | 0 | 31 |
| 12558577 | Anti-human Trop-2 antibody and application thereof | 🖼🧊📄§ | 2026-02-24 | 2040-10-12 | 0 | 31 |
| 12558351 | Compositions and methods for enhancing cancer immune checkpoint therapy | 🖼🧊📄§ | 2026-02-24 | 2040-03-20 | 0 | 31 |
| 12558407 | Compositions for treatment of diffuse intrinsic pontine glioma | 🖼🧊📄§ | 2026-02-24 | 2040-05-01 | 0 | 31 |
| 12559552 | IL-23 and TNF-alpha binding bi-specific heavy chain polypeptides | 🖼🧊📄§ | 2026-02-24 | 2040-06-19 | 0 | 31 |
| 12559471 | 1,5-dihydro-2,4-benzodiazepine-3-one derivative and application thereof | 🖼🧊📄§ | 2026-02-24 | 2042-10-20 | 0 | 31 |
| 12559726 | Universal donor cells | 🖼🧊📄§ | 2026-02-24 | 2043-01-06 | 0 | 31 |
| 12558361 | Method and composition for treating non-cirrhotic NASH | 🖼🧊📄§ | 2026-02-24 | 2044-03-15 | 0 | 31 |
| 12559545 | Human hendra virus and nipah virus antibodies and methods of use therefor | 🖼🧊📄§ | 2026-02-24 | 2040-11-12 | 0 | 31 |
| 12558400 | Method of treatment of soft tissue sarcoma with a peptide comrpising a PCNA interacting motif | 🖼🧊📄§ | 2026-02-24 | 2041-04-27 | 0 | 31 |
| 12558358 | N-(furan-2-ylmethyl)-7H-purin-6-amine for treatment of circadian rhythm diseases, disorders and dysfunctions | 🖼🧊📄§ | 2026-02-24 | 2040-12-08 | 0 | 31 |
| 12558387 | Multi-virus anti-infectivity and pro-immunity assembly | 🖼🧊📄§ | 2026-02-24 | 2042-06-07 | 0 | 31 |
| 12559499 | Uses of compounds having anti-HSV-1 activity | 🖼🧊📄§ | 2026-02-24 | 2040-01-29 | 0 | 31 |
| 12558396 | Use of cyclo(His-Pro) (CHP) for preventing, alleviating or treating peritoneal fibrosis | 🖼🧊📄§ | 2026-02-24 | 2040-03-30 | 0 | 31 |
| 12558352 | Use of malic enzyme 1 (ME1) in preparation of drug for preventing and treating pulmonary hypertension (PH) | 🖼🧊📄§ | 2026-02-24 | 2043-06-09 | 0 | 31 |
| 12558340 | ANAVEX2-73 for the treatment of genetic neurodevelopmental disorders | 🖼🧊📄§ | 2026-02-24 | 2042-01-21 | 0 | 31 |
| 12559719 | Engineered expression of cell surface and secreted sialidase by CAR T cells for increased efficacy in solid tumors | 🖼🧊📄§ | 2026-02-24 | 2044-03-29 | 0 | 31 |
| 12558421 | Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereof | 🖼🧊📄§ | 2026-02-24 | 2043-05-23 | 0 | 31 |
| 12559563 | Müllerian inhibiting substance type 2 receptor (MISIIR)-specific CAR T cells for the treatment of ovarian cancer and other gynecologic malignancies | 🖼🧊📄§ | 2026-02-24 | 2040-04-14 | 0 | 31 |